Trial Profile
Drug-drug interaction study between gefitinib and docetaxel in Patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gefitinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 12 Dec 2015 New trial record